Aug 02 2018 0 MGB Biopharma awarded £2.78m grant for Phase IIa trial By Jonathan | News MGB Biopharma is developing a novel class of anti-infectives based on minor groove binders (MGBs), based on technology developed by Professor Colin Suckling at the University of Strathclyde. The company...Read More
